Cardiovascular and Cerebrovascular Control in Healthy Subjects
CardioSan
1 other identifier
observational
60
1 country
1
Brief Summary
The aim of the study is to evaluate autonomic function and cerebrovascular control in 60 healthy subjects by means of noninvasive analysis of time series variability. To this extent, heart period, systolic and mean arterial blood pressure, cerebral blood velocity, peripheral resistances, respiration will be recorded from subjects during an orthostatic challenge. The interactions between autonomic cardiovascular function, cerebrovascular and peripheral control will be evaluated exploiting the most advanced signal processing techniques.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 23, 2023
CompletedFirst Posted
Study publicly available on registry
January 31, 2023
CompletedStudy Start
First participant enrolled
May 29, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2027
March 28, 2025
March 1, 2025
4.3 years
January 23, 2023
March 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluate the state and interactions of autonomic function and cerebrovascular control
12 months
Study Arms (1)
Healthy
60 healthy subjects; age \>18; sinus rhythm; absence of autonomic diseases or dysfunctions.
Interventions
Data are acquired with patients resting in supine position for 10 minutes and for 10 minutes during active standing
Eligibility Criteria
Healthy subjects
You may qualify if:
- age \>18
- sinus rhythm
- informed consent signed
You may not qualify if:
- age \<18
- presence of autonomic nervous system diseases or dysfunctions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Policlinico San Donato
San Donato Milanese, Milan, 20097, Italy
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, PhD
Study Record Dates
First Submitted
January 23, 2023
First Posted
January 31, 2023
Study Start
May 29, 2023
Primary Completion (Estimated)
October 1, 2027
Study Completion (Estimated)
October 1, 2027
Last Updated
March 28, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share